𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel

✍ Scribed by Broide, Etty ;Zeigler, Marcia ;Eckstein, Joseph ;Bach, Gideon


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
325 KB
Volume
47
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

✦ Synopsis


A screening program for the detection of Tay-Sachs disease (TSD) carriers in the ultra Orthodox community of Ashkenazi J e w s has operated in Israel since 1986. The purpose of this program is the prevention of marriages of 2 heterozygotes. The screened individuals are mostly couples in the engagement process or students in religious high schools. Two mandatory requirements guide this program.

First, anonymity of the tested individuals who are identified only by code numbers; second completion of the test results of couples in the engagement process within a few days. The screening program is performed by the determination of hexosaminidase A (Hex A) activity in serum which is repeated in serum and leukocyte extracts in couples where both partners were found in the heterozygote range in the initial tests.

The minimal carrier frequency was estimated to be 1:26 or higher, which is higher then in the general Jewish Ashkenazi population. This higher carrier frequency apparently stems from the fact that most members of this community originate from central Europe where the TSD carrier frequency was previously reported to be the highest in the Ashkenazi population. Since the beginning of the screening program no TSD child has been born to newlywed couples of this community in Israel.


πŸ“œ SIMILAR VOLUMES


Population-based Tay-Sachs screening amo
✍ Adele Schneider; Sachiko Nakagawa; Rosanne Keep; Darnelle Dorsainville; Joel Cha πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 1 views

## Abstract Tay‐Sachs disease (TSD) carrier screening, initiated in the 1970s, has reduced the birth‐rate of Ashkenazi Jews with TSD worldwide by 90%. Recently, several nationwide programs have been established that provide carrier screening for the updated panel of Jewish genetic diseases on colle